Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with relapsing-remitting multiple sclerosis (RRMS), confirmed using a specific set of medical guidelines called the 2017 McDonald criteria
- You are either switching from a strong MS medication to a less intensive one, or stopping a lower-strength MS medication altogether
- You own a smartphone (this requirement applies to the main study centre only)
- Your level of physical disability is below a certain threshold, measured by a standard MS scale called the EDSS, with a score below 7.0 (confirm with trial site)
- You are able to use a smartphone independently (this requirement applies to the main study centre only)
Who may not be able to join:
- You have had a recent MS relapse or have received steroid treatment through a drip, or a blood-filtering treatment called immunoadsorption, within the last six weeks
- You have another health condition that might make it difficult for you to understand or complete the study, such as certain mental health conditions or dementia — the trial team will make this decision on a case-by-case basis
- You have been diagnosed with primary progressive MS or secondary progressive MS (rather than the relapsing-remitting form)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marc Günter Pawlitzki, PD Dr. med., Heinrich-Heine University, Duesseldorf
Phone: +49 02118117887
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of disease activity, measured by loss of NEDA at month 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.